WO2015052568A3 - Formes solides de curcumine et de dérivés de curcumine - Google Patents

Formes solides de curcumine et de dérivés de curcumine Download PDF

Info

Publication number
WO2015052568A3
WO2015052568A3 PCT/IB2014/002034 IB2014002034W WO2015052568A3 WO 2015052568 A3 WO2015052568 A3 WO 2015052568A3 IB 2014002034 W IB2014002034 W IB 2014002034W WO 2015052568 A3 WO2015052568 A3 WO 2015052568A3
Authority
WO
WIPO (PCT)
Prior art keywords
curcumin
derivatives
solid forms
crystals
preparation
Prior art date
Application number
PCT/IB2014/002034
Other languages
English (en)
Other versions
WO2015052568A2 (fr
Inventor
Satyanarayana Chava
Seeta Rama Anjaneyulu GORANTLA
Vamsee Krishna Muppidi
Original Assignee
Laurus Labs Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laurus Labs Private Limited filed Critical Laurus Labs Private Limited
Publication of WO2015052568A2 publication Critical patent/WO2015052568A2/fr
Publication of WO2015052568A3 publication Critical patent/WO2015052568A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des formes solides de curcumine et de dérivés de celle-ci, y compris des polymorphes et des co-cristaux, un procédé de préparation desdites formes solides et une composition les contenant.
PCT/IB2014/002034 2013-10-07 2014-10-06 Formes solides de curcumine et de dérivés de curcumine WO2015052568A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN4518/CHE/2013 2013-10-07
IN4518CH2013 2013-10-07
IN4749CH2013 2013-10-21
IN4749/CHE/2013 2013-10-21

Publications (2)

Publication Number Publication Date
WO2015052568A2 WO2015052568A2 (fr) 2015-04-16
WO2015052568A3 true WO2015052568A3 (fr) 2015-06-18

Family

ID=52813709

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2014/002034 WO2015052568A2 (fr) 2013-10-07 2014-10-06 Formes solides de curcumine et de dérivés de curcumine

Country Status (1)

Country Link
WO (1) WO2015052568A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE1850403A1 (en) 2018-04-11 2019-10-12 Letavis Ab Co-crystals
MX2019010692A (es) * 2019-09-06 2022-07-06 Alparis Sa De Cv Compuestos de curcumina y aminoácidos básicos.
WO2021202872A1 (fr) * 2020-04-01 2021-10-07 Natural Extraction Systems, LLC Compositions et procédés associés à des isomères de curcumine
GB202011069D0 (en) 2020-07-17 2020-09-02 Univ Of Lincoln New curcumin products and uses

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012138907A2 (fr) * 2011-04-05 2012-10-11 Translational Genomics Research Institute Formes solubles de curcumine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012138907A2 (fr) * 2011-04-05 2012-10-11 Translational Genomics Research Institute Formes solubles de curcumine

Also Published As

Publication number Publication date
WO2015052568A2 (fr) 2015-04-16

Similar Documents

Publication Publication Date Title
EP3402787A4 (fr) Procédés de préparation d'acide 2,5-furandicarboxylique et des intermédiaires et dérivés correspondants
EP3349762A4 (fr) Co-cristaux d'inhibiteurs de sglt2, procédé pour leur préparation et compositions pharmaceutiques de ceux-ci
WO2015085318A3 (fr) Vaccins adaptatifs ciblés
HK1232229A1 (zh) '- '-硫代核苷的新型化合物及其製備方法、藥物組合物和應用
WO2014162320A3 (fr) Nouveaux analogues d'épicatéchine et polyphénols associés
WO2015191945A3 (fr) Formes solides de sofosbuvir
WO2016013030A3 (fr) Composés hydroxystéroïdes, leurs intermédiaires, procédé de préparation, composition et utilisations de ceux-ci
EP4327880A3 (fr) Forme à l'état solide de succinate de ribociclib
WO2016009401A3 (fr) Préparation du phosphate de tédizolid
WO2016092561A3 (fr) Nouveaux polymorphes d'ivacaftor, procédé de préparation de cette molécule et composition pharmaceutique la contenant
WO2015029074A3 (fr) Compositions d'eltrombopag
WO2017008136A3 (fr) Composés de cbd fluorés, compositions et leurs utilisations
WO2015092810A3 (fr) Forme amorphe d'idélalisib
WO2012137227A3 (fr) Formes solides de composés antirétroviraux, procédé de préparation correspondant et composition pharmaceutique de ces composés
WO2016166720A3 (fr) Polymorphes et procédé pour la préparation de dérivés de quinazolinyle
WO2015197534A3 (fr) Procédés pour la préparation de composés hétérocycliques 1,3-benzodioxole
CA2922375C (fr) Formes de sels d'alpha-tea: compositions et utilisations therapeutiques
WO2015052568A3 (fr) Formes solides de curcumine et de dérivés de curcumine
EP3390369A4 (fr) Formes solides de composés 5,6-dihydro-6-phénylbenzo[f]isoquinoléine-2-amine substituée
WO2015111004A3 (fr) Méthode améliorée de préparation de chlorophényl-trifluoroéthanone
WO2016063289A3 (fr) Compositions de comprimé pharmaceutique comprenant de la rifaximine
WO2017029642A3 (fr) Nouveaux polymorphes du dolutégravir et leurs sels
WO2014159501A3 (fr) Procédés de préparation de tetrahydroisoquinoleines
WO2014102759A3 (fr) Procédé de préparation de dasatinib et de ses intermédiaires
WO2017046816A3 (fr) Procédé pour la préparation de dérivés de benzodioxole

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14852542

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 14852542

Country of ref document: EP

Kind code of ref document: A2